Friday, July 10, 2026

pharma · Recurrent Cervical Carcinoma

Lei Li

Lei Li trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Intelligence · Clinical Trials

Lei Li clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Lei Li programs — each row shows trial ID, program name, phase, status, and indication.

Lei Li trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Lei Li.

  1. Chemotherapy plus apatinib — Phase 2

    Clinical update

Trial registry

1 studies